Understand how the rare relative of ovarian cancer is diagnosed and treated. Joanne Wilson was feeling less like herself — she was always tired, sometimes struggling just to get up in the morning, and ...

Intratumoral Ral-binding protein 1 (RalBP1) expression as a potential predictor of bevacizumab treatment efficacy in patients with ovarian cancer. This is an ASCO Meeting Abstract from the 2024 ASCO ...

Main driver genes and BRCA mutation in Chinese patients with pancreatic adenocarcinoma. Nab-paclitaxel/S-1(AS) versus nab-paclitaxel/gemcitabine(AG) for first-line ...

Please provide your email address to receive an email when new articles are posted on . The addition of intraperitoneal paclitaxel to systemic capecitabine and oxaliplatin appeared to benefit patients ...

Elahere is a type of targeted therapy called an antibody-drug conjugate. This antibody-drug conjugate is made up of an antibody that is attached to a cancer medicine. Elahere is used to treat a type ...

Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway ...

As blood in the peritoneal capillaries comes into contact with dialysate in the peritoneal cavity, solutes in the blood diffuse into the dialysate. The osmotic gradient created by glucose in the ...

PPC is a type of cancer that starts in the peritoneal cavity in the abdomen, rather than cancer that has developed elsewhere in the body and spread to the peritoneum. Cancer that has started elsewhere ...